【肺癌】《Median》獲4,750萬歐元融資，將用於肺癌診斷「eyonis™」在美國和歐盟商業化

 【肺癌】《Median》獲4,750萬歐元融資，將用於肺癌診斷「eyonis™」在美國和歐盟商業化

 文章出處  

Businesswire 

 

 原文標題  

Median Technologies securing up to €47.5 million to support AI lung cancer diagnostic eyonis™ regulatory filings and commercialization in U.S. and EU 

 

 Twitter  

https://x.com/aimedadviser/status/1883129446418579576 

 

 文章序號  

7168 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2025 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.